Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738566 · ClinicalTrials.gov registry record · NA
Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03738566: Completed NA study, sponsored by Mayo Clinic.
NCT03738566 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738566, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.
Interventions
- DEVICE Esophageal self-dilation therapy
- PROCEDURE Endoscopic therapy with esophageal dilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-11-21 |
| Est. Completion | 2022-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03738566
The ClinicalTrials.gov registry entry for NCT03738566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Esophageal self-dilation therapy is the first listed.
NCT03738566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03738566 about?
NCT03738566 is a clinical study titled "Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management". This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.
What is the current status of trial NCT03738566?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-11-21. Estimated completion is 2022-05-15.
What interventions are being tested in trial NCT03738566?
The interventions under investigation include: Esophageal self-dilation therapy (DEVICE), Endoscopic therapy with esophageal dilation (PROCEDURE).
Who is sponsoring clinical trial NCT03738566?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.